ROQUETTE: A GLOBAL SUPPLIER FOR GLOBAL NEEDS
Roquette is a long-established supplier of actives and excipients, associated to many services, to the pharmaceutical and cosmetics industries. Whatever your requirements and aims, discover Roquette Pharma's Solutions.
ROQUETTE: A GLOBAL SUPPLIER FOR GLOBAL NEEDS
To meet customers’ needs, a wide range of excipients and actives are available in Roquette’s portofolio, notably in the areas of:
- Injectables (enteral and parenteral nutrition)
- Tablets obtained by direct compression or wet granulation
- Film forming and film coating
- Syrups, suspensions, Granules and sachets
- Orodispersible tablets
- OTC and nutraceuticals
- Toothpastes and mouthwashes
- Encapsulation
As solution provider, new associated services are also proposed:
Roquette now offers on-site assistance for LYCOAT®, film coating polymer, and ReadiLYCOAT® , ready-to-use coating systems. LYCOAT® has proven to be exceptionally inert, unlike other coating polymers. To obtain more process insights: www.readilycoat.com.
Today, the direct scale-up of formulations offers a new way to reduce drug development time and cost. To further strengthen this drive, Roquette and the Institut de la Garonne have pooled their expertise to provide a new compression modeling service.
To be as close as possible to your demand, Roquette is constantly strengthening its worldwide presence. You can find your local contact on our website.
At Roquette we help you formulate whatever you want, whenever you want, wherever you want.
Company name: ROQUETTE
Website: www.roquettepharma.com
E-mail: pharma.business.unit@roquette.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
